National Institutes of Health: Glioma trials

The registry lists 120 Glioma studies with National Institutes of Health as lead sponsor. 4 are open to participants now and 52 have results posted.

Phase 1 65Phase 2 63Phase 3 1No phase 11(a study in two phases counts in both)

Studies

Page 2 of 2. Open to participants first, then studies with results posted, then the rest; newest registration first within each.

• Tipifarnib in Treating Young Patients With Recurrent or Progressive High-Grade Glioma, Medulloblastoma, Primitive Neuroectodermal Tumor, or Brain Stem GliomaCompletedNCT00070525Phase 2
• Talampanel in Treating Patients With Recurrent High-Grade GliomaCompletedNCT00064363Phase 2
• Cilengitide in Treating Children With Refractory Primary Brain TumorsCompletedNCT00063973Phase 1
• The Role of Gene Changes in Brain Tumor Formation and GrowthCompletedNCT00059020
• FR901228 in Treating Children With Refractory or Recurrent Solid Tumors or LeukemiaCompletedNCT00053963Phase 1
• Temozolomide and O6-Benzylguanine in Treating Children With Recurrent Brain TumorsCompletedNCT00052780Phase 1
• Arsenic Trioxide Plus Radiation Therapy in Treating Patients With Newly Diagnosed Malignant GliomaCompletedNCT00045565Phase 1
• Brachytherapy in Treating Patients With Recurrent Malignant GliomaCompletedNCT00045474Phase 1
• CC-5013 in Treating Patients With Recurrent GliomaCompletedNCT00036894Phase 1
• Genetic Analysis of Brain TumorsTerminatedNCT00031538
• Erlotinib in Treating Patients With Solid Tumors and Liver or Kidney DysfunctionCompletedNCT00030498Phase 1
• Stereotactic Radiosurgery in Treating Patients With Brain TumorsCompletedNCT00019578Phase 1
• Atrasentan in Treating Patients With Progressive or Recurrent Malignant GliomaCompletedNCT00017264Phase 1
• Karenitecin in Treating Patients With Recurrent Malignant GliomaCompletedNCT00014521Phase 1
• Flavopiridol in Treating Children With Relapsed or Refractory Solid Tumors or LymphomasCompletedNCT00012181Phase 1
• Natural History of Patients With Brain and Spinal Cord TumorsCompletedNCT00009035
• Pyrazoloacridine Plus Carboplatin in Treating Patients With Recurrent GliomaCompletedNCT00005976Phase 2
• O6-Benzylguanine and Carmustine Implants in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004892Phase 1
• Carmustine in Treating Patients With Recurrent Malignant GliomaCompletedNCT00004028Phase 1
• Motexafin Gadolinium Plus Radiation Therapy in Treating Children With Newly Diagnosed Brain Stem GliomaCompletedNCT00003909Phase 1